Cebix, Inc. Employee Directory
Pharmaceutical ManufacturingCalifornia, United States0-1 Employees
Cebix, Inc. is a pharmaceutical manufacturing company based in San Diego, California. The firm is developing Ersatta, a long-acting, disease-modifying replacement peptide intended to address diabetes-related complications rather than merely alleviate symptoms. The company appears to have a small team. The target patients include individuals with type 1 diabetes and some with type 2 diabetes who have a deficiency in C-peptide, which can contribute to reduced microvascular circulation and progressive damage to nerves, the retina, and kidneys. Cebix is evaluating Ersatta in a Phase 2 clinical trial in type 1 diabetes patients. The description notes that there are few available treatments for these microvascular complications and no approved drugs specifically addressing the microvascular damage.